Nu Skin Enterprises, Inc. (NUS) Stake Lowered by Ingalls & Snyder LLC

Ingalls & Snyder LLC cut its stake in Nu Skin Enterprises, Inc. (NYSE:NUS) by 3.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,846 shares of the company’s stock after selling 1,695 shares during the period. Ingalls & Snyder LLC owned approximately 0.10% of Nu Skin Enterprises worth $2,991,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the company. Creative Planning raised its position in shares of Nu Skin Enterprises by 38.5% in the first quarter. Creative Planning now owns 1,800 shares of the company’s stock valued at $100,000 after buying an additional 500 shares in the last quarter. TrimTabs Asset Management LLC raised its position in shares of Nu Skin Enterprises by 88.7% in the first quarter. TrimTabs Asset Management LLC now owns 2,349 shares of the company’s stock valued at $130,000 after buying an additional 1,104 shares in the last quarter. Independent Portfolio Consultants Inc. raised its position in shares of Nu Skin Enterprises by 1.7% in the first quarter. Independent Portfolio Consultants Inc. now owns 2,375 shares of the company’s stock valued at $132,000 after buying an additional 40 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Nu Skin Enterprises by 23.0% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,506 shares of the company’s stock valued at $139,000 after buying an additional 468 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC raised its position in shares of Nu Skin Enterprises by 87.5% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 3,811 shares of the company’s stock valued at $182,000 after buying an additional 1,779 shares in the last quarter. Hedge funds and other institutional investors own 78.88% of the company’s stock.

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Nu Skin Enterprises, Inc. (NYSE:NUS) traded up 0.63% during midday trading on Friday, reaching $55.90. 407,487 shares of the company’s stock were exchanged. The stock’s 50 day moving average is $55.61 and its 200 day moving average is $52.68. The firm has a market capitalization of $2.95 billion, a P/E ratio of 18.55 and a beta of 1.66. Nu Skin Enterprises, Inc. has a 52 week low of $38.34 and a 52 week high of $66.04.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Wednesday, May 3rd. The company reported $0.51 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.01. The firm had revenue of $499.10 million for the quarter, compared to analysts’ expectations of $493.65 million. Nu Skin Enterprises had a net margin of 6.26% and a return on equity of 20.06%. Nu Skin Enterprises’s revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.42 earnings per share. On average, analysts expect that Nu Skin Enterprises, Inc. will post $3.12 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 14th. Shareholders of record on Friday, May 26th will be given a dividend of $0.36 per share. The ex-dividend date of this dividend is Wednesday, May 24th. This represents a $1.44 dividend on an annualized basis and a yield of 2.59%. Nu Skin Enterprises’s dividend payout ratio (DPR) is 57.96%.

TRADEMARK VIOLATION WARNING: “Nu Skin Enterprises, Inc. (NUS) Stake Lowered by Ingalls & Snyder LLC” was reported by Transcript Daily and is the property of of Transcript Daily. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at https://transcriptdaily.com/2017/05/20/nu-skin-enterprises-inc-nus-stake-lowered-by-ingalls-snyder-llc.html.

Several brokerages have recently commented on NUS. Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating in a report on Saturday, February 25th. Pivotal Research restated a “buy” rating and issued a $65.00 price objective on shares of Nu Skin Enterprises in a report on Thursday, May 4th. Deutsche Bank AG restated a “buy” rating and issued a $63.00 price objective on shares of Nu Skin Enterprises in a report on Sunday, February 19th. Jefferies Group LLC set a $52.00 price objective on shares of Nu Skin Enterprises and gave the stock a “hold” rating in a report on Friday, February 17th. Finally, Sidoti lowered shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 price objective on the stock. in a report on Wednesday, April 26th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $59.00.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 16,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Monday, March 6th. The shares were sold at an average price of $50.00, for a total transaction of $800,000.00. Following the transaction, the general counsel now directly owns 45,730 shares of the company’s stock, valued at $2,286,500. The sale was disclosed in a filing with the SEC, which is available at this link. Over the last ninety days, insiders have sold 32,000 shares of company stock worth $1,708,960. 4.60% of the stock is currently owned by corporate insiders.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

12 Month Chart for NYSE:NUS

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply